Stanford-StartX has contributed to a seed round for Scoutible, which uses machine learning technology to improve the recruitment process.

ImaginAb, a UCLA spinout that has now raised approximately $4m in total, will continue development of the imaging agent it is developing for T-cell tumours.

Beta Bionics has been launched as a public benefit corporation to commercialise automated bihormonal pumps for type 1 diabetes sufferers.

The spinout has turned to Stanford-Start X Fund as it prepares to add data sciences, engineering and clinical features to its machine-learning based service for health insurers.

The cardiovascular software developer has built modelling programs that could help doctors decide whether patients are fit for surgery.

Rodeo Therapeutics has developed therapies to regenerate tissue, based on research undertaken at Case Western Reserve University and University of Texas Southwestern Medical Center.